FDA Clears Theranos’ HSV-1 Finger Prick Test and System
The 510(k) clearance includes the company’s finger stick and venous blood test, its patented Nanotainer tubes, and analytical software. FDA Approvals …read more
The 510(k) clearance includes the company’s finger stick and venous blood test, its patented Nanotainer tubes, and analytical software. FDA Approvals …read more
Participation in Michigan’s statewide Medicaid enhanced prenatal care program led to significant reductions in infant mortality and newborn deaths among families insured by Medicaid, according to a… …read more
Pregnant women with a history of epilepsy are at increased risk for death and complications during delivery, according to a new study. It is estimated that women with a history of epilepsy comprise… …read more
A mutation newly identified in a morbidly obese individual shuts down production of an enzyme known to affect insulin production and appetite suppression, as well as other hormones. Medscape Medical News …read more
The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine issued a joint opinion on the appropriate use of cell-free fetal DNA screening. Medscape Medical News …read more
While heart disease is the number one cause of death in both sexes, it poses special considerations in women–with risks often beginning in childhood and changing at different stages of life. …read more
With the number of individuals affected by cognitive decline expected to rise over the next few decades, investigating its potential causes is of major public health interest. …read more
Pregnancy and motherhood are both wonderful and worrisome times – could public health campaigns and social stereotypes be contributing to anxiety for mothers? …read more
LISBON – Dilation and curettage increases the risk for prematurity in subsequent pregnancy, according to a systematic review and meta-analysis of nearly 2 million women. Overall, D&C for… …read more
LISBON – Expectant management is a safe and effective treatment for incomplete miscarriage after misoprostol, results of the MisoREST trial show. “Because it is non-invasive, we think it should be… …read more